Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunan Li

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Nature Communications|July 3, 2024
Unraveling distinct effects between CuO<sub>x</sub> and PtCu alloy sites in Pt-Cu bimetallic catalysts for CO oxidation at different temperaturesYunan Li, Lingling Guo, Meng Du, et al.
Journal of the American Chemical Society|May 15, 2026
State-Specific Nonresonant and Resonant Plasmon-Driven Electron Transfer into Single MoleculesZhiwei Liu, Jiayu Xu, Xiang Zhu, et al.
Advances in Therapy|November 19, 2020
Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study : Treatment pattern and outcomes in patients with multiple myelomaJianming He, Luke Schmerold, Rian Van Rampelbergh, et al.
Medical Oncology (Northwood, London, England)|November 23, 2011
Clinical implications of ERβ methylation on sporadic breast cancers in Chinese womenLin Zhao, Zhaojin Yu, Yunan Li, et al.
National Science Review|April 14, 2026
Engineering single topological π-conjugated polymers and interpolating topological solitons by end-group modificationZhengya Wang, Yunan Li, Bin Li, et al.
Advanced Drug Delivery Reviews|April 24, 2026
Challenges and delivery strategies for PROTACs in central nervous system therapeuticsXinuo Li, Jinran Li, Yuan Sun, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2023
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Nature Communications|July 3, 2024
Unraveling distinct effects between CuO<sub>x</sub> and PtCu alloy sites in Pt-Cu bimetallic catalysts for CO oxidation at different temperaturesYunan Li, Lingling Guo, Meng Du, et al.
Journal of the American Chemical Society|May 15, 2026
State-Specific Nonresonant and Resonant Plasmon-Driven Electron Transfer into Single MoleculesZhiwei Liu, Jiayu Xu, Xiang Zhu, et al.
Advances in Therapy|November 19, 2020
Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study : Treatment pattern and outcomes in patients with multiple myelomaJianming He, Luke Schmerold, Rian Van Rampelbergh, et al.
Medical Oncology (Northwood, London, England)|November 23, 2011
Clinical implications of ERβ methylation on sporadic breast cancers in Chinese womenLin Zhao, Zhaojin Yu, Yunan Li, et al.
National Science Review|April 14, 2026
Engineering single topological π-conjugated polymers and interpolating topological solitons by end-group modificationZhengya Wang, Yunan Li, Bin Li, et al.
Advanced Drug Delivery Reviews|April 24, 2026
Challenges and delivery strategies for PROTACs in central nervous system therapeuticsXinuo Li, Jinran Li, Yuan Sun, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2023
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Pageof 6